Suchergebnisse - "Capdevila, Jaume"

PubPharm (18)

1

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology : A Subgroup Analysis of the COSMIC-311 Study

enthalten in: Thyroid : official journal of the American Thyroid Association | 2024

von Capdevila, J. | Krajewska, J. | Hernando, J. | +13

2

LIBRETTO-531 : a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer

enthalten in: Future oncology (London, England) | 2022

von Wirth, L. | Brose, M. | Elisei, R. | +9

3

Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era

enthalten in: Cancer treatment reviews | 2022

von Capdevila, J. | Awada, A. | Führer-Sakel, D. | +2

4

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

enthalten in: Thyroid : official journal of the American Thyroid Association | 2022

von Capdevila, J. | Klochikhin, A. | Leboulleux, S. | +15

5

Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Lenvatinib

enthalten in: Thyroid : official journal of the American Thyroid Association | 2021

von Taylor, M. | Takahashi, S. | Capdevila, J. | +10

6

Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors : Results of the Phase II TALENT Trial (GETNE1509)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Capdevila, J. | Fazio, N. | Lopez, C. | +26

7

Advanced Pancreatic Neuroendocrine Neoplasms : Which Systemic Treatment Should I Start With?

enthalten in: Current oncology reports | 2021

von Rodriguez-Freixinos, V. | Thawer, A. | Capdevila, J. | +2

8

Drug Development in Neuroendocrine Tumors : What Is on the Horizon?

enthalten in: Current treatment options in oncology | 2021

von Garcia-Alvarez, A. | Hernando Cubero, J. | Capdevila, J.

9

Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Capdevila, J. | Arqués, O. | Hernández Mora, J. | +17

10

Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer

enthalten in: Cancer treatment reviews | 2018

von Capdevila, J. | Newbold, K. | Licitra, L. | +6